Literature DB >> 22948665

Thymus, thymoma and myasthenia gravis.

Yoshitaka Fujii1.   

Abstract

Myasthenia gravis is an autoimmune disease. An autoantibody directed toward acetylcholine receptor (AChR) causes the destruction of the postsynaptic membrane and a reduction of the number of AChRs at neuromuscular junctions. A very puzzling, but interesting characteristic of myasthenia gravis is that many of the patients have an abnormality in their thymus. Many have a hyperplastic thymus with germinal centers, while others have a thymic tumor. How is the abnormality of the thymus related to myasthenia gravis? This review will summarize the existing evidence and try to find the missing link between the thymus and myasthenia gravis. The review will also comment on two distinct populations of myasthenia gravis patients without thymoma. The autoimmunity found in elderly patients is nonspecific and initiated via a different mechanism from the initiation of myasthenia gravis in younger patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948665     DOI: 10.1007/s00595-012-0318-2

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  24 in total

1.  Pseudo-myasthenia gravis and thymic hyperplasia in Graves' disease.

Authors:  M W Nicolle
Journal:  Can J Neurol Sci       Date:  1999-08       Impact factor: 2.104

2.  Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.

Authors:  Y Fujii; J Hashimoto; Y Monden; T Ito; K Nakahara; Y Kawashima
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

3.  Ectopic expression of peripheral-tissue antigens in the thymic epithelium: probabilistic, monoallelic, misinitiated.

Authors:  Jennifer Villaseñor; Whitney Besse; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-03       Impact factor: 11.205

4.  Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.

Authors:  W Hoch; J McConville; S Helms; J Newsom-Davis; A Melms; A Vincent
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

Review 5.  Myasthenia gravis.

Authors:  J Lindstrom; D Shelton; Y Fujii
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

6.  Autoantibody profiles and neurological correlations of thymoma.

Authors:  Steven Vernino; Vanda A Lennon
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

7.  Infrequent and low AIRE expression in thymoma: difference in AIRE expression among WHO subtypes does not correlate with association of MG.

Authors:  Eriko Suzuki; Yoshihiro Kobayashi; Motoki Yano; Yoshitaka Fujii
Journal:  Autoimmunity       Date:  2008-08       Impact factor: 2.815

8.  Evidence of underdiagnosis of myasthenia gravis in older people.

Authors:  A Vincent; L Clover; C Buckley; J Grimley Evans; P M Rothwell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

9.  Thymoma-associated graft-versus-host disease-like erythroderma.

Authors:  Tomoyuki Nakagiri; Meinoshin Okumura; Masayoshi Inoue; Masato Minami; Eiji Kiyohara; Noriko Umegaki; Toshiaki Nakamura; Yasuhiko Tomita; Ichirou Katayama; Katsuyuki Aozasa
Journal:  J Thorac Oncol       Date:  2007-12       Impact factor: 15.609

10.  The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics.

Authors:  Marguerite E Hill; Hiroyuki Shiono; John Newsom-Davis; Nick Willcox
Journal:  J Neuroimmunol       Date:  2008-08-22       Impact factor: 3.478

View more
  18 in total

1.  Taste disorder in a patient with invasive thymoma without myasthenia gravis: a rare case report.

Authors:  Takayuki Kosaka; Hirotaka Nakahashi; Seshiru Nakazawa; Takashi Ibe; Toshiki Yajima; Ken Shirabe
Journal:  Mediastinum       Date:  2022-03-25

Review 2.  Advances in autoimmune myasthenia gravis management.

Authors:  Shuhui Wang; Iva Breskovska; Shreya Gandhy; Anna Rostedt Punga; Jeffery T Guptill; Henry J Kaminski
Journal:  Expert Rev Neurother       Date:  2018-07-04       Impact factor: 4.618

3.  Myasthenia gravis in patients with thymoma affects survival rate following extended thymectomy.

Authors:  Zhefeng Zhang; Youbin Cui; Rui Jia; Lei Xue; Huagang Liang
Journal:  Oncol Lett       Date:  2016-05-05       Impact factor: 2.967

Review 4.  Long Non-Coding RNAs in the Cell Fate Determination of Neoplastic Thymic Epithelial Cells.

Authors:  Alessia Iaiza; Claudia Tito; Federica Ganci; Andrea Sacconi; Enzo Gallo; Silvia Masciarelli; Giulia Fontemaggi; Alessandro Fatica; Enrico Melis; Vincenzo Petrozza; Federico Venuta; Mirella Marino; Giovanni Blandino; Francesco Fazi
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

5.  Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes.

Authors:  ZhaoHui Luo; Ye Li; XiaoFang Liu; MengChuan Luo; LiQun Xu; YueBei Luo; Bo Xiao; Huan Yang
Journal:  BMC Med Genomics       Date:  2015-03-18       Impact factor: 3.063

6.  Myasthenia gravis as a prognostic marker in patients with thymoma.

Authors:  Bernardo Cacho-Díaz; Karen Salmerón-Moreno; Nydia A Lorenzana-Mendoza; Julia Texcocano; Oscar Arrieta
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

7.  A chondrosarcoma in the anterior mediastinum mimicking a thymoma.

Authors:  Mia L Østergaard; Rene H Petersen; Anna Kalhauge
Journal:  Acta Radiol Open       Date:  2015-09-08

8.  Risk Factors and Outcomes in Cats with Acquired Myasthenia Gravis (2001-2012).

Authors:  D W Hague; H D Humphries; M A Mitchell; G D Shelton
Journal:  J Vet Intern Med       Date:  2015-08-26       Impact factor: 3.333

9.  Cerebral toxoplasmosis in a patient with myasthenia gravis and thymoma with immunodeficiency/Good's syndrome: a case report.

Authors:  Sarah C Sasson; Sarah Davies; Raymond Chan; Leo Davies; Roger Garsia
Journal:  BMC Infect Dis       Date:  2016-08-30       Impact factor: 3.090

10.  The Effect of Immunonutrition on the Postoperative Complications in Thymoma with Myasthenia Gravis.

Authors:  Yanzhong Xin; Hongfei Cai; Lihui Wu; Youbin Cui
Journal:  Mediators Inflamm       Date:  2016-11-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.